Skip to main content
Mirube

Anesthesiology - Quarterly Reports

List of quarterly reports on Anesthesiology

Anesthesiology Research Analysis

Research during 2026-Q3 shifted anesthesiology toward individualized, mechanism-informed, and outcome-focused care. Large randomized trials challenged routine assumptions about anesthetic technique, airway devices, corticosteroid prophylaxis, and universal perioperative interventions. Translational studies advanced mechanistic understanding of postoperative cognitive dysfunction, developmental anesthetic neurotoxicity, cerebral venous-lymphatic physiology, and environmental thrombotic risk. Meth

Anesthesiology Research Analysis

Q2 2026 anesthesiology was defined by atomic-level mechanistic pharmacology, organelle-targeted biology, and implementable safety innovations. Structural studies recast ketamine’s action via direct opioid-receptor activation and located a conserved volatile anesthetic pocket on voltage-gated sodium channels, offering blueprints for safer, selective agents. Translational advances spanned non-opioid analgesia (NTSR2 agonism), organ preservation through ferroptosis inhibition on ex situ machine per

Anesthesiology Research Analysis

Q1 2026 anesthesiology research coalesced around precision, biomarker-guided critical care and neuro-technologies that bridge mechanism to practice. Two Lancet Respiratory Medicine papers anchored a precision sepsis arc: a validated three-biomarker ML framework (DIP/cDIP) enabling stratified immunomodulation, and a Bayesian, biomarker-enriched phase 3 trial suggesting mortality reduction with polymyxin B hemoadsorption in endotoxic shock. Cross-species adversarial AI mapped mechanistic biomarker

Anesthesiology Research Analysis

The quarter marked a clear transition from universal perioperative protocols toward individualized, physiology- and biomarker-guided care. Large randomized trials supported capillary refill time–guided septic-shock resuscitation and biomarker-enriched prevention of postoperative acute kidney injury, while PROTHOR showed that routine high PEEP with recruitment does not improve pulmonary outcomes and increases hemodynamic harm. Mechanistic advances were substantial, including time-resolved structu

Anesthesiology Research Analysis

The third quarter of 2025 shifted anesthesiology toward precision, mechanism-based, and pragmatic perioperative science. Large randomized trials challenged routine use of BIS-guided anesthesia and supported simple safety interventions such as lateral positioning during procedural sedation, while other trials refined regional anesthesia and pediatric ICU sedation choices. Translational studies identified potentially reversible biological mechanisms involving myocardial membrane cholesterol, RIPK1

Anesthesiology Research Analysis

The second quarter of 2025 showed a clear shift toward physiology-guided, mechanism-informed, and recovery-oriented anesthesiology. Randomized clinical evidence supported less invasive regional analgesia, remimazolam-based strategies for frail older adults, hemodynamically safer induction, and nitric-oxide-mediated renal protection. Large-scale machine-learning work demonstrated that perioperative prediction tools are approaching practical implementation, particularly for transfusion stewardship

Anesthesiology Research Analysis

The quarter marked a shift from broad perioperative interventions toward mechanism-based, phenotype-guided anesthesiology. Large randomized and evidence-synthesis studies strengthened respiratory safety, cardiac-surgical blood management, perfusion-system design, prehabilitation, and individualized anesthetic selection. Translational work identified new biological mechanisms, including rocuronium-specific IgE epitopes, Piezo2-mediated vascular mechanosensation, and cortical circuit control of bu